Biomarkers

TMD provides comprehensive biomarker services for pharmaceutical and biotechnlogy companies developing targeted cancer therapeutics. We work with our clients to help them design and execute adaptive, biomarker-driven clinical trials that may considerably shorten the time and cost of bringing a drug to market. TMD's approach to biomarker selection and assay design for a given agent is driven by a thorough understanding of the underlying systems biology. While many laboratories are "technology specific", TMD believes firmly in choosing the best available technology for each analyte and tumor type - we are comfortable with new technologies and utilize them well! Sample disease, therapy, and mechanism specific panels are shown at right.

To consult with TMD’s Translational Biomarker Specialists, call 866.897.7350 ex 213 or email TMD Translational Biomarker Services at biomarkers@tmdlab.com.

TMD adds to its portfolio of validated biomarkers regularly, please call for the most current list or to inquire about developing an off the menu custom assay.